Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Anika Therapeutics (ANIK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 859,516
  • Shares Outstanding, K 14,660
  • Annual Sales, $ 103,380 K
  • Annual Income, $ 32,550 K
  • 36-Month Beta 1.44
  • Price/Sales 7.82
  • Price/Cash Flow 23.52
  • Price/Book 3.38

Price Performance

See More
Period Period Low Period High Performance
1-Month
51.88 +13.01%
on 12/21/17
59.24 -1.03%
on 01/17/18
+5.19 (+9.71%)
since 12/15/17
3-Month
51.10 +14.74%
on 10/26/17
60.29 -2.75%
on 10/23/17
-0.95 (-1.59%)
since 10/17/17
52-Week
41.64 +40.80%
on 03/28/17
60.29 -2.75%
on 10/23/17
+8.57 (+17.12%)
since 01/17/17

Most Recent Stories

More News
Anika Therapeutics Receives FDA Nod for Bone Repair Therapy

Anika Therapeutics' (ANIK) FDA approved HA-based injectable bone repair therapy provides a commercial edge to regenerative portfolio.

AKTX : 3.77 (+1.89%)
ANIK : 58.63 (+0.46%)
XOMA : 32.63 (+3.39%)
ITGR : 48.40 (unch)
Hovnanian and Kindred climb while Callaway Golf slumps

NEW YORK (AP) — Stocks that moved substantially or traded heavily Wednesday:

KND : 9.30 (+1.64%)
SPPI : 19.41 (+2.16%)
AMAT : 57.34 (+5.21%)
ANIK : 58.63 (+0.46%)
ELY : 14.21 (+2.97%)
AWK : 82.51 (+0.35%)
HOV : 2.67 (+0.75%)
Anika Announces FDA 510(k) Clearance for Its Injectable HA-Based Bone Repair Treatment

Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA") technology,...

ANIK : 58.63 (+0.46%)
Anika Therapeutics, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / October 26, 2017 / Anika Therapeutics, Inc. (NASDAQ: ANIK) will be discussing their earnings results in their Q3 Earnings Call to be held on October 26, 2017 at 9:00 AM Eastern...

ANIK : 58.63 (+0.46%)
Anika Reports Third Quarter 2017 Financial Results

Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA") technology,...

ANIK : 58.63 (+0.46%)
Anika Completes Enrollment in Second Pivotal Phase III Trial of CINGAL for the Treatment of Knee Pain Associated with Osteoarthritis

Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA") technology,...

ANIK : 58.63 (+0.46%)
Global Hyaluronic Acid Market 2017-2021 - Key Vendors are ALLERGAN, Anika Therapeutics, Sanofi, SEIKAGAKU & Zimmer Biomet

DUBLIN, October 17, 2017 /PRNewswire/ --

ANIK : 58.63 (+0.46%)
Global Hyaluronic Acid Market 2017-2021 - Key Vendors are ALLERGAN, Anika Therapeutics, Sanofi, SEIKAGAKU & Zimmer Biomet

The "Global Hyaluronic Acid Market 2017-2021" report has been added to Research and Markets' offering.

ANIK : 58.63 (+0.46%)
Anika Announces Regulatory Approval for MONOVISC(R) in Australia for the Treatment of Pain Associated with Osteoarthritis of all Synovial Joints

Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA") technology,...

ANIK : 58.63 (+0.46%)
Anika Announces Appointment of Steven Chartier as Vice President of Regulatory and Clinical Affairs

Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA") technology,...

ANIK : 58.63 (+0.46%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators mostly agree with the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More

Business Summary

Anika Therapeutics, Inc. is a global, integrated orthopedic medicines company based in Bedford, Massachusetts. Anika is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies along the continuum of care, from palliative...

See More

Key Turning Points

2nd Resistance Point 60.00
1st Resistance Point 59.31
Last Price 58.63
1st Support Level 57.87
2nd Support Level 57.12

See More

52-Week High 60.29
Last Price 58.63
Fibonacci 61.8% 53.17
Fibonacci 50% 50.97
Fibonacci 38.2% 48.76
52-Week Low 41.64

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.